Schedule 13D ownership disclosure
AERPIO PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 00810B105
Event date: 2019-03-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,482,904
- Percent of class
- 13.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-018338
- Form type
- SC 13D
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Mar 28, 2019
- Reporting period
- Mar 26, 2019
- Description
- Schedule 13D beneficial ownership